A compound found in rosemary and sage, carnosic acid, has been turned into a promising treatment for Alzheimer’s disease. Scientists at the Scripps Research Institute have developed a drug derived from it, called diAcCA, which significantly reduces brain inflammation and restores memory in mice.
Key Facts:
- Carnosic acid, found in rosemary and sage, has anti-inflammatory properties.
- Scripps researchers created a derivative, diAcCA, that effectively reaches the brain.
- Mice treated with diAcCA regained cognitive function and had fewer Alzheimer’s-related plaques.
- DiAcCA only activates in inflamed areas, reducing potential side effects.
- Since carnosic acid is FDA-approved, the treatment may be fast-tracked for clinical trials.
The Rest of The Story:
Alzheimer’s disease affects millions of Americans, leading to memory loss and cognitive decline.
Researchers have struggled to find a safe, effective treatment, but this new discovery offers fresh hope.
The Scripps team tested diAcCA on mice genetically bred to develop Alzheimer’s-like symptoms.
After three months of treatment, the mice performed significantly better in memory-based tests, such as navigating a water maze and recalling fear-based stimuli.
Under a microscope, their brains showed fewer plaques, less inflammation, and stronger neural connections.
Unlike traditional drugs, diAcCA activates only in inflamed areas, avoiding the side effects that often come with treatments affecting healthy tissue.
Scientists believe this breakthrough could revolutionize Alzheimer’s treatment and possibly enhance existing therapies.
Scripps Research scientists have created a diAcCA, a stabilized form of carnosic acid—an antioxidant in rosemary and sage—potentially improving memory, fortifying neuronal connections & reducing brain inflammation— a promising therapeutic for Alzheimer’s. https://t.co/e5YXtmHxW7 pic.twitter.com/TTvWlK4epn
— Scripps Research (@scrippsresearch) March 18, 2025
Commentary:
If this discovery translates to humans, it could be a medical breakthrough unlike any we’ve seen.
A simple compound from kitchen herbs may hold the answer to one of the most devastating diseases of our time.
This should prompt serious discussion about why natural treatments have been overlooked for so long.
For decades, big pharmaceutical companies have controlled the development of treatments, often favoring high-cost drugs with complex patents over simpler, natural solutions.
The fact that a widely available herb could yield such powerful results raises questions about how many other low-cost treatments have been ignored.
With new leadership under RFK, there is hope that alternative therapies like diAcCA will receive the attention they deserve.
If carnosic acid proves effective in human trials, it could mean a shift away from the monopolized, profit-driven model that has long dictated healthcare.
Patients and families suffering from Alzheimer’s deserve access to treatments that work, regardless of whether they come from a lab or a spice rack.
The Bottom Line:
A derivative of rosemary and sage could be the key to reversing Alzheimer’s disease.
Early research shows diAcCA dramatically improves brain function in mice, and its FDA-approved origins could fast-track human trials.
If this works, it could change how we approach medicine—proving that some of the best treatments have been hiding in plain sight.
Read Next
– England Just Committed Cultural Suicide, It’s Over For Them
– Houthi Terror Chief Responds to Trump’s Air Strikes, He Just Made a BIG Mistake
– Trump Issues Statement Regarding Biden’s Pre-Emptive Pardons, This is HUGE